Latest news with #ShardaCropchem
&w=3840&q=100)
Business Standard
6 hours ago
- Business
- Business Standard
Stock calls, July 4: Natco Pharma, Sharda Cropchem among top stocks to buy
Stocks to buy: Analyst pick Sharda Cropchem, Monarch Networth Capital and one more share to buy; Check full details Kunal Kamble Mumbai Stock recommendations Sharda Cropchem Sharda Cropchem has given a breakout above its resistance level and closed higher, indicating buyer dominance. The rise in volume during the breakout confirms strong buying interest at current levels. The stock is trading above all major Exponential Moving Averages (EMAs), suggesting a firm positive trend. The RSI, after a brief consolidation, has turned upward, supporting the ongoing price action. Additionally, DI+ trading above DI- signals a bullish stance, while the ADX above both DI lines reflects strength in the upmove. The stock can be accumulated at current levels, with a stop-loss at ₹830 and an upside target of ₹998. Sharda Cropchem: ₹886.90 Stop loss: ₹830 Monarch Networth Capital Monarch Networth has given a breakout from its recent trading range, accompanied by a rise in volume, indicating buyer dominance over sellers. The stock has managed to close above all major EMAs, which suggests the trend remains positive. The RSI is moving higher, supporting the ongoing price action. Additionally, DI+ trading above DI- indicates a bullish bias, while the ADX trading above DI− signals strength in the current upmove. The stock can be accumulated in the range of ₹355–₹372, with a stop-loss at ₹337, for an upside target of ₹391–₹450. Monarch Networth Capital: ₹371.95 Stop Loss: ₹337 Target Price: ₹391/₹450 Natco Pharma Natco Pharma has taken support near the ₹890 level, which previously acted as a strong base from where the stock had rallied up to ₹1,639. Once again, buyers have stepped in at this level, pushing the price higher to ₹973, with the stock now closing above the 9, 21, and 50 EMAs on the weekly timeframe-a sign of emerging bullish momentum. The rise in volume confirms buying interest at current levels. The RSI has crossed above the 50 mark, indicating improving momentum. Additionally, on the weekly chart, DI+ has crossed above DI−, further supporting the positive outlook. The stock can be accumulated on dips toward ₹912, with a stop-loss at ₹840, for an upside target of ₹1,140–₹1,200. Natco Pharma: ₹973.60 Stop Loss: ₹840 Target Price: ₹1140/₹1200
Mint
a day ago
- Business
- Mint
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 3 July 2025
Breakout stocks buy or sell: Indian equities ended in the red on Wednesday as investors continued profit-booking in financial stocks after a recent rally, with selling pressure extending to public sector banks. Despite hopes of a possible US-India trade agreement, market sentiment remained subdued. The Nifty 50 fell 0.38% to close at 25,443, while the Sensex declined by 287 points to end at 83,409. Broader market indices also slipped, with the Nifty Midcap 100 easing 0.14% and the Nifty Smallcap 100 losing 0.41%. Sumeet Bagadia, Executive Director at Choice Broking, believes that Indian stock market sentiment is positive but the Nifty 50 index is facing hurdle at 25,650 to 25,700 zone. Speaking on the outlook of Indian stock market, Bagadia said, ' On breaking this hurdle on a closing basis, we can expect the 50-stock index to touch 26,200 soon. On the lower side, Nifty today has immediate support at 25,500, whereas it has crucial support at 25,250 to 25,200 range. So, one should maintain stock-specific approach and look at those stocks that are looking strong on the technical chart. Looking at breakout stocks can be a good option." Sumeet Bagadia recommends five breakout stocks to buy today: Subros, Tatva Chintan Pharma Chem, Sharda Cropchem, Pocl Enterprises, and LT Foods. 1] Subros: Buy at ₹ 1003.1, target ₹ 1075, stop loss ₹ 965; 2] Tatva Chintan Pharma Chem: Buy at ₹ 997.4, target ₹ 1070, stop loss ₹ 960; 3] Sharda Cropchem: Buy at ₹ 844.8, target ₹ 905, stop loss ₹ 815; 4] Pocl Enterprises: Buy at ₹ 897.85, target ₹ 965, stop loss ₹ 865; 5] LT Foods: Buy at ₹ 494.75, target ₹ 530, stop loss ₹ 477. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
Mint
29-05-2025
- Business
- Mint
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 29 May 2025
Breakout stocks buy or sell: The benchmark indices, Sensex and Nifty 50, declined for a second straight session on Wednesday, May 29, due to weak global signals. The Sensex dropped 239 points, or 0.29%, to settle at 81,312.32, while the Nifty 50 slipped 74 points, or 0.30%, closing at 24,752.45. Meanwhile, the BSE Midcap index also finished in the red, down 0.22%, but the Small-cap index moved against the trend, gaining 0.50%. Sumeet Bagadia, Executive Director at Choice Broking, believes that the undertone for the Indian stock market is positive but the Nifty 50 index is facing hurdle at 25,000 levels. Speaking on the outlook of Indian stock market, Bagadia said, ' On breaching above this resistance, we can expect the benchmark index to touch 25,400 soon. On the lower side, the index has made strong support at 24,500 levels. So, one should maintain stock-specific approach and look at those stocks that are looking strong on the technical chart. Looking at breakout stocks can be a good option." Sumeet Bagadia recommends five shares to buy today — Pearl Global Industries, Sharda Cropchem, Bhagiradha Chemicals and Industries, PPAP Automotive, and Deepak Frtlsrs and Ptrchmcls Corp. 1] Pearl Global Industries: Buy at ₹ 1422, target ₹ 1515, stop loss ₹ 1370; 2] Sharda Cropchem: Buy at ₹ 730, target ₹ 775, stop loss ₹ 703; 3] Bhagiradha Chemicals and Industries: Buy at ₹ 327.8, target ₹ 350, stop loss ₹ 315; 4] PPAP Automotive: Buy at ₹ 224.27, target ₹ 239, stop loss ₹ 216; 5] Deepak Frtlsrs and Ptrchmcls Corp: Buy at ₹ 1444.7, target ₹ 1550, stop loss ₹ 1400. Disclaimer: The views and recommendations provided in this analysis are those of individual analysts or broking companies, not Mint. We strongly advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and individual circumstances may vary.
Business Standard
14-05-2025
- Business
- Business Standard
Sharda Cropchem consolidated net profit rises 41.89% in the March 2025 quarter
Sales rise 39.36% to Rs 1828.53 crore Net profit of Sharda Cropchem rose 41.89% to Rs 203.57 crore in the quarter ended March 2025 as against Rs 143.47 crore during the previous quarter ended March 2024. Sales rose 39.36% to Rs 1828.53 crore in the quarter ended March 2025 as against Rs 1312.05 crore during the previous quarter ended March 2024. For the full year,net profit rose 854.77% to Rs 304.38 crore in the year ended March 2025 as against Rs 31.88 crore during the previous year ended March 2024. Sales rose 36.57% to Rs 4319.85 crore in the year ended March 2025 as against Rs 3163.02 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 1828.531312.05 39 4319.853163.02 37 OPM % 16.5819.42 - 13.798.94 - PBDT 328.00252.66 30 653.00339.00 93 PBT 256.11198.41 29 378.3471.87 426 NP 203.57143.47 42 304.3831.88 855
Business Standard
14-05-2025
- Business
- Business Standard
Sharda Cropchem standalone net profit rises 0.25% in the March 2025 quarter
Sales rise 36.00% to Rs 1614.39 crore Net profit of Sharda Cropchem rose 0.25% to Rs 183.06 crore in the quarter ended March 2025 as against Rs 182.60 crore during the previous quarter ended March 2024. Sales rose 36.00% to Rs 1614.39 crore in the quarter ended March 2025 as against Rs 1187.05 crore during the previous quarter ended March 2024. For the full year,net profit rose 100.16% to Rs 273.74 crore in the year ended March 2025 as against Rs 136.76 crore during the previous year ended March 2024. Sales rose 40.67% to Rs 3661.10 crore in the year ended March 2025 as against Rs 2602.67 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 1614.391187.05 36 3661.102602.67 41 OPM % 14.5719.67 - 12.126.65 - PBDT 300.39288.64 4 617.46442.12 40 PBT 228.51234.40 -3 342.85175.04 96 NP 183.06182.60 0 273.74136.76 100
